Neuropace, Inc. · NASDAQ:NPCE

Orbimed Advisors LLC reported a 6.20% stake in Neuropace, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Orbimed Advisors LLC reported a 6.20% stake in Neuropace, Inc., 2,096,527 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
6.20%
Shares
2,096,527
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
OrbiMed Advisors LLC6.20%2,096,527
OrbiMed Capital GP VI LLC6.20%2,096,527

Source

View original at SEC

Related